You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

ACETASOL HC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Acetasol Hc, and when can generic versions of Acetasol Hc launch?

Acetasol Hc is a drug marketed by Actavis Mid Atlantic and is included in one NDA.

The generic ingredient in ACETASOL HC is acetic acid, glacial; hydrocortisone. There are thirty-six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the acetic acid, glacial; hydrocortisone profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ACETASOL HC?
  • What are the global sales for ACETASOL HC?
  • What is Average Wholesale Price for ACETASOL HC?
Summary for ACETASOL HC
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 2
Patent Applications: 4,258
DailyMed Link:ACETASOL HC at DailyMed
Drug patent expirations by year for ACETASOL HC

US Patents and Regulatory Information for ACETASOL HC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic ACETASOL HC acetic acid, glacial; hydrocortisone SOLUTION/DROPS;OTIC 087143-001 Jan 13, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

ACETASOL HC Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for ACETASOL HC

Introduction to ACETASOL HC

ACETASOL HC is a combination medication used to treat outer ear infections, such as swimmer's ear. It contains two active ingredients: acetic acid and hydrocortisone. Here, we will delve into the market dynamics and financial trajectory of this drug.

Market Demand and Usage

ACETASOL HC is prescribed for treating otitis externa, a common condition that affects many individuals, particularly those involved in water activities. The demand for this medication is steady due to its effectiveness in treating ear infections.

  • Seasonal Demand: The demand for ACETASOL HC can be seasonal, with higher usage during summer months when swimming and water activities are more common[5].

Pricing and Cost Structure

The pricing of ACETASOL HC can vary based on several factors, including the formulation (solution or drops), concentration, and the pharmacy or healthcare provider.

  • Retail Pricing: The retail price of ACETASOL HC ear solution can range from $20 to $50 for a typical 10ml bottle, depending on the pharmacy and location[5].
  • Hospital and Clinical Pricing: In a hospital setting, the pricing can be different. For example, the price for ACETASOL HC 1%-2% ear solution can be around $482.20 per 10ml bottle, as seen in some hospital charge masters[2].

Generic and Brand Competition

The market for ACETASOL HC includes both brand-name and generic versions.

  • Generic Competition: The approval of generic versions of ACETASOL HC can significantly impact the market dynamics. Generic medications often reduce the market share of brand-name drugs due to their lower prices. For instance, the FDA approval of generic medications can lead to a decrease in the prices of the original brand-name drugs[1].

Financial Performance

The financial performance of ACETASOL HC can be analyzed through various metrics:

  • Sales Volume: The sales volume of ACETASOL HC can be substantial, given its widespread use. For example, if we consider the data from Oklahoma's Medicaid program, medications like ACETASOL HC, although not explicitly mentioned, fall under categories that show significant prescription volumes and associated costs[1].
  • Revenue: The revenue generated from ACETASOL HC sales can be considerable. However, this revenue can fluctuate based on factors such as competition from generics, changes in pricing, and variations in demand.

Cost-Effectiveness and Value

The cost-effectiveness of ACETASOL HC is an important factor in its market dynamics.

  • Clinical Effectiveness: ACETASOL HC is clinically effective in treating outer ear infections, which contributes to its market value. The combination of acetic acid and hydrocortisone provides both antibacterial and anti-inflammatory effects, making it a preferred treatment option[5].
  • Long-Term Value: Similar to other medications, the long-term value of ACETASOL HC can be influenced by factors such as patent expirations and the introduction of new indications. As seen with other drugs, the cost-effectiveness ratio can decrease over the life cycle of the drug, making it more valuable in the long term[3].

Regulatory Environment

The regulatory environment plays a crucial role in the market dynamics of ACETASOL HC.

  • FDA Approvals: The FDA approval process is critical for any medication. For ACETASOL HC, maintaining FDA approval and compliance with regulatory standards is essential for its continued market presence[5].
  • Patent Status: The patent status of ACETASOL HC affects its market exclusivity. Once patents expire, generic versions can enter the market, potentially reducing the market share of the brand-name drug[1].

Market Trends and Future Outlook

Several trends influence the future outlook of ACETASOL HC:

  • Increasing Generic Competition: The trend of increasing generic competition is likely to continue, which could impact the pricing and market share of ACETASOL HC.
  • Advancements in Treatment Options: Any advancements in treatment options for outer ear infections could also affect the demand for ACETASOL HC.
  • Healthcare Policy Changes: Changes in healthcare policies, such as those related to reimbursement and coverage, can also influence the financial trajectory of ACETASOL HC.

Key Takeaways

  • Stable Demand: ACETASOL HC has a stable demand due to its effectiveness in treating common ear infections.
  • Pricing Variability: The pricing of ACETASOL HC varies based on the setting and the presence of generic alternatives.
  • Cost-Effectiveness: The medication is clinically effective, contributing to its long-term value.
  • Regulatory Impact: FDA approvals and patent status significantly influence the market dynamics.
  • Future Outlook: The market will likely be influenced by increasing generic competition and potential advancements in treatment options.

FAQs

Q: What is ACETASOL HC used for? A: ACETASOL HC is used to treat outer ear infections, such as swimmer's ear.

Q: How does the pricing of ACETASOL HC vary? A: The pricing of ACETASOL HC can vary based on the retail or hospital setting and the presence of generic alternatives.

Q: What are the key components of ACETASOL HC? A: ACETASOL HC contains acetic acid and hydrocortisone.

Q: How does generic competition affect ACETASOL HC? A: Generic competition can reduce the market share and pricing of brand-name ACETASOL HC.

Q: What factors influence the long-term value of ACETASOL HC? A: The long-term value of ACETASOL HC is influenced by its clinical effectiveness, patent status, and regulatory environment.

Sources

  1. Oklahoma.gov: Published Annual Reviews - Oklahoma.gov
  2. Adena Health System: Chg Master for Jean - Adena Health System
  3. PubMed: Dynamic cost-effectiveness of oncology drugs
  4. DrugBank: Hydrocortisone: Uses, Interactions, Mechanism of Action
  5. WebMD: Acetasol HC 1 %-2 % Ear Solution - Uses, Side Effects, and More

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.